May 17 (Reuters) - Activist investor Elliott Investment
Management has built a sizable stake in Bio-Rad Laboratories ( BIO/B )
and plans to push the supplier of life-science tools and
diagnostics products to boost its underperforming stock price,
the Wall Street Journal reported on Sunday.
Reuters could not immediately verify the WSJ report.
(Reporting by Rishabh Jaiswal in Bengaluru; Editing by
Subhranshu Sahu)